iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionEnvestnet Asset Management Inc
Latest Disclosed Ownership1,226,668 shares
Latest Disclosed Value $ 207,122,859
Envestnet Asset Management Inc reports 0.30% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 4, 2026 - Envestnet Asset Management Inc filed a 13F-HR form disclosing ownership of 1,226,668 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $207,122,859 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,223,050 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.30% during the quarter. The current value of the position is $160,754,841 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,226,668 3,618 0.30 207,123 0.34 0.0554
2026-02-10 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,223,050 1,172,666 2,327.46 206,414 2,738.09 0.0612
2025-11-05 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 50,384 -5,695 -10.16 7,274 2.52 0.0021
2025-08-01 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 56,079 3,051 5.75 7,095 4.60 0.0021
2025-04-29 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 53,028 -3,941 -6.92 6,782 -9.95 0.0022
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 56,969 1,138 2.04 7,532 -7.36 0.0024
2024-11-07 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 55,831 -6,827 -10.90 8,129 -5.48 0.0026
2024-08-08 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 62,658 -4,135 -6.19 8,600 -6.16 0.0030
2024-05-13 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 66,793 9,067 15.71 9,165 16.87 0.0034
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 57,726 -13,231 -18.65 7,842 -9.62 0.0032
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 70,957 -18,407 -20.60 8,677 -23.52 0.0040
2023-08-04 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 89,364 -4,697 -4.99 11,346 -6.61 0.0050
2023-05-11 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 94,061 -101,304 -51.85 12,149 -52.64 0.0058
2023-02-07 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 195,365 35,253 22.02 25,649 36.96 0.0133
2022-11-10 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 160,112 35,655 28.65 18,727 27.92 0.0107
2022-08-03 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 124,457 -14,449 -10.40 14,640 -19.11 0.0082
2022-05-04 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 138,906 -17,504 -11.19 18,099 -24.18 0.0091
2022-02-04 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 156,410 8,915 6.04 23,871 0.10 0.0118
2021-10-07 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 147,495 -5,887 -3.84 23,847 -5.00 0.0131
2021-08-04 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 153,382 -27,468 -15.19 25,101 -7.82 0.0143
2021-05-04 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 180,850 -102,414 -36.15 27,229 -36.55 0.0177
2021-02-02 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 283,264 -151,813 -34.89 42,912 -27.16 0.0324
2020-10-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 435,077 14,393 3.42 58,914 2.45 0.0522
2020-07-08 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 420,684 328,599 356.84 57,503 479.61 0.0563
2020-04-23 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 92,085 11,882 14.81 9,921 2.65 0.0118
2020-02-11 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 80,203 1,755 2.24 9,665 23.82 0.0102
2019-10-17 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 78,448 -13,182 -14.39 7,806 -21.92 0.0085
2019-08-02 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 91,630 -3,304 -3.48 9,997 -5.81 0.0126
2019-05-10 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 94,934 23,011 31.99 10,614 53.03 0.0146
2019-02-12 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 71,923 53,935 299.84 6,936 216.28 0.0107
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 17,988 -7,601 -29.70 2,193 -21.96 0.0038
2018-08-10 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 25,589 7 0.03 2,810 5.28 0.0064
2018-05-09 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 25,582 -4,305 -14.40 2,669 -16.38 0.0075
2018-02-20 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 29,887 -20,470 -40.65 3,192 -81.00 0.0071
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 50,357 8,897 21.46 16,797 30.62 0.0402
2017-08-14 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 41,460 6,917 20.02 12,859 26.94 0.0356
2017-05-09 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 34,543 12,773 58.67 10,130 75.29 0.0324
2017-02-14 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 21,770 6,519 42.74 5,779 30.92 0.0210
2016-11-14 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 15,251 1,496 10.88 4,414 24.69 0.0171
2016-08-15 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 13,755 1,560 12.79 3,540 11.29 0.0141
2016-05-16 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 12,195 -22,319 -64.67 3,181 -72.76 0.0137
2016-02-16 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 34,514 -51,505 -59.88 11,677 -55.25 0.0530
2015-11-13 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 86,019 -22,031 -20.39 26,092 -34.55 0.1296
2015-08-13 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 108,050 15,313 16.51 39,867 25.18 0.1897
2015-05-15 2015-03-31 13F ISHARES TR NASDQ BIO INDX 464287556 92,737 49,354 113.76 31,849 142.01 0.1647
2015-02-12 2014-12-31 13F Ishares Nasdaq Biotechnology ETF 464287556 43,383 -7,569 -14.86 13,160 -5.61 0.1338
2014-11-13 2014-09-30 13F Ishares Nasdaq Biotechnology ETF 464287556 50,952 15,111 42.16 13,942 51.35 0.1403
2014-08-14 2014-06-30 13F * ISHARES NASDQ BIOTEC ETF 464287556 35,841 31,201 672.44 9,212 739.74 0.0958
2014-05-12 2014-03-31 13F Ishares Nasdaq Biotechnology ETF 464287556 4,640 2,074 80.83 1,097 88.16 0.0122
2014-02-12 2013-12-31 13F Ishares Nasdaq Biotechnology ETF 464287556 2,566 -4,013 -61.00 583 -57.72 0.0067
2013-11-12 2013-09-30 13F Ishares Nasdaq Biotechnology ETF 464287556 6,579 3,783 135.30 1,379 183.74 0.0168
2013-08-09 2013-06-30 13F Ishares Nasdaq BioTech. ETF 464287556 2,796 2,796 486 0.0063
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.